United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 19, 2026 · Filed Oct 20, 2026

On Oct 19, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$543.32 for US$5.16M under a trading plan, leaving 324,443 shares. Filed Oct 20, 2026 (Form 4).

Sold
9,500 shares
Price
US$543.32 average (US$534.75 to US$556.88)
Value
US$5.16M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 19, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 19, 2026Common StockSale160US$534.75333,783Indirect
Oct 19, 2026Common StockSale360US$536.36333,423Indirect
Oct 19, 2026Common StockSale240US$537.11333,183Indirect
Oct 19, 2026Common StockSale160US$538.54333,023Indirect
Oct 19, 2026Common StockSale880US$539.79332,143Indirect
Oct 19, 2026Common StockSale1,800US$540.63330,343Indirect
Oct 19, 2026Common StockSale520US$541.38329,823Indirect
Oct 19, 2026Common StockSale260US$542.81329,563Indirect
Oct 19, 2026Common StockSale1,240US$543.73328,323Indirect
Oct 19, 2026Common StockSale1,040US$544.89327,283Indirect
Oct 19, 2026Common StockSale1,065US$545.90326,218Indirect
Oct 19, 2026Common StockSale416US$547.00325,802Indirect
Oct 19, 2026Common StockSale559US$547.98325,243Indirect
Oct 19, 2026Common StockSale360US$549.01324,883Indirect
Oct 19, 2026Common StockSale120US$549.66324,763Indirect
Oct 19, 2026Common StockSale80US$551.78324,683Indirect
Oct 19, 2026Common StockSale40US$552.78324,643Indirect
Oct 19, 2026Common StockSale120US$554.00324,523Indirect
Oct 19, 2026Common StockSale80US$556.88324,443Indirect

Source

Download original · View original at SEC

Related